Podcasts about off script

Is it possible to be so close to the Bible that you actually miss the heart of Jesus?  In this episode of Off Script, Neil sits down with Lydia Florence and Connor Hall to discuss a sermon on the healing of the blind man. Connor shares his "method" approach to sermon prep, practicing in total darkness, and dives into the research he did on different types of blindness. The team examines "Cracker Barrel Christianity," the danger of spiritual pride among those who study Scripture deeply, and why we often try to make Jesus more like us instead of becoming more like Him.  The Challenge Identify one "southern saying" or cultural idea about God you've relied on more than actual Scripture.  Hosts: Neil Gregory, Connor Hall, and Lydia Florence.  What We Discuss Connor's "method" sermon prep: practicing in the dark to better understand the blind man's perspective.  The decision to preach without notes, images, or props to keep the focus entirely on the Word.  Why a full page of "marshmallow fluff" was cut from the final sermon.  Fascinating research on blindness, including how those born blind dream differently than those who lost their sight.  "Cracker Barrel Christianity": Why southern sayings like "God gives his toughest battles to his strongest soldiers" aren't actually in the Bible.  The "Bless This Mess" mentality, why we want Jesus to bless our chaos rather than transform it.  The danger of spiritual elitism and "holy huddles" where we study the Bible but never reach the lost.  Why teachers will be judged more strictly and the weight of living out what you preach. Addressing the tendency to try to make Jesus "cool" or popular so that we can feel accepted by culture.  The truth about the Christian life: it will rarely be easy, but it will always be worth it.  About Southland Christian Church Southland is one church meeting in multiple locations across central Kentucky. We believe Jesus came for the lost and the broken, which means there's a place for everyone here. Around here, that means we worship defiantly, speak truth unashamedly, and extend grace generously. To support this ministry and help us continue to reach across Central Kentucky and all around the world, visit: https://southland.church/give

Welcome to Albion - our exploration of what it means to be English, and what we mean by England.In this episode of OffScript, Dash Arts' Artistic Director Josephine Burton is joined by Caroline Lucas for a thoughtful and urgent conversation about Englishness - beyond flags and nostalgia.Drawing on her book Another England, Caroline shares her thoughts on how land, belonging and identity shape our politics and our culture; how England's stories have been constructed and contested; and why reclaiming a generous, complex vision of England matters now.Since 2022, Dash Arts has been digging into landscape and language - from reimagining Middlemarch by George Eliot in 1980s Coventry, to running speech-making workshops with more than 600 people across the country. We've been listening to who we are — and who we could be.Join us as we ask: what does Englishness mean to you?Albion will culminate in 2026 with our new touring theatre production, Our Public House. Get your tickets and to find out more on the Dash Arts website : https://www.dasharts.org.uk/our-public-house Our intro music is Fakiiritanssi by Marouf Majidi Hosted on Acast. See acast.com/privacy for more information.

As biologics grow more complex, cell line development remains a key driver of speed, yield, and manufacturability. What was once a technical milestone is now a competitive differentiator, directly impacting time to Investigational New Drug (IND), cost of goods, and long-term scalability. In this episode of Off Script, we spoke with Brett Verstak, director of cell line development at Abzena, to discuss how advanced Chinese hamster ovary (CHO)-based platforms, glutamine synthetase (GS) knockout systems, automation, and AI-driven workflows are accelerating clone selection and reducing downstream risk. The conversation explores persistent bottlenecks in hard-to-express proteins, the value of integrated upstream development models, and how smarter platform design is helping drug developers move complex biologics to the clinic faster.

RenMac unpacks cooler inflation that keeps Fed cuts in play just as rising job anxiety and narrow hiring trends point to softer labor conditions beneath the surface. The team debates the growing AI vs. non-AI market bifurcation, fragile tech momentum, tight credit spreads versus private credit stress, tariff maneuvering around chips and Taiwan, and what housing, manufacturing, and D.C. drama signal for markets ahead.

Send a textDiscover the human story behind the man who co-founded E! Entertainment Television and revolutionized celebrity culture. In this episode of The Corporate Life, Larry Namer shares his journey from being rejected over 100 times by investors to building a $10 billion media empire. Learn why he believes following your passion is bad advice and how "not knowing the rules" allowed him to dominate 142 countries.Key TakeawaysSuccess demands risk and the courage to ignore family and peers who suggest playing it safe.Innovation often comes from a lack of industry baggage; Namer's team of interns became VPs by breaking traditional media rules.Focus on what you are good at rather than just your hobbies to build the financial freedom to pursue your passions later.Episode HighlightsHow a 2.5 million dollar investment and 31 college interns launched a global network.The creation of "Talk Soup" and the strategy of treating celebrities as people, not just headlines.Why Larry views Hollywood as a "state of mind" rather than a geographic location in the age of iPhone filmmaking.Timestamps02:16 — Building the first 61-channel cable system 04:22 — Facing 100+ rejections and the birth of E! 06:12 — Starting with 11 employees and 31 interns 13:46 — Leaving a secure career for the ultimate risk 21:50 — A quick-fire round on instinct vs. data 24:38 — "Off Script": Blending a memoir with a cookbookConnect with GuestInstagram: @LarryNamerTV Email: ljn@ljnmedia.comConnect with HinaWEBSITE I https://thehinasiddiqui.com/ LINKEDIN I / hinasiddiqui INSTAGRAM I @hinawithwings YOUTUBE I / @thehinasiddiqui Email I hina@thehinasiddiqui.comCheck out Hina's books: https://amzn.to/3B65Wz7Production Credit: Edited and produced by @the32collective_ / https://www.the32collective.co/

As cell and gene therapies continue to deliver promising clinical results, manufacturing remains one of the biggest barriers to broader commercialization. Persistent challenges around cost, complexity, labor intensity, and vein-to-vein timelines—particularly for autologous CAR-T therapies—are limiting the industry's ability to scale beyond niche and last-line indications. Addressing these constraints will be critical if CGTs are to move earlier in treatment paradigms and reach more patients globally. In this episode of Off Script, we spoke with Jon Ellis, CEO of Trenchant BioSystems, about the current state of cell and gene therapy manufacturing and where the industry must go next. The conversation explores why traditional centralized manufacturing models are struggling to scale, how automation and digital batch records can significantly compress manufacturing timelines, and how emerging platforms are rethinking cell recovery, analytics integration, and starting material strategies.

There's a moment every coach knows. You're mid-session. Your client says something unexpected. The conversation shifts — emotionally, directionally, energetically. And suddenly, you feel it: I don't know what to do next. In this episode, I'm talking about why that moment isn't a coaching failure — and why, in many cases, it's actually a sign that you're doing real, meaningful work. We're unpacking the fear that lives underneath “not knowing,” why so many coaches panic when sessions don't go as planned, and how much of that anxiety comes from holding an unspoken agenda about where the session should go. I also explore the difference between agenda-driven, outcome-focused coaching and curiosity-driven, co-active coaching — and why letting go of the need to steer your client toward a specific insight, solution, or action often creates far more powerful results. This is a conversation about trust. Trusting the process. Trusting your client. And trusting yourself as a coach — even (and especially) when you don't have the answers. If you've ever left a session second-guessing yourself, wondering if you handled it “right,” or thinking you need more training just to feel confident in the room — this episode is for you. LINKS + RESOURCES

CNBC's Sara Eisen joins the RenMac Off-Script team to unpack why Big Tech's AI spend is suddenly spooking markets, cracking momentum trades, and pressuring software stocks. The team breaks down softening labor signals beneath solid GDP growth, Bitcoin's risk warning, FX stress abroad, the views of the Davos elite and what a potential Kevin Warsh Fed chair could mean for markets.

Improvisation is one of the most intimidating skills for new Game Masters. What happens when players ignore your prep, ask unexpected questions, or make choices you didn't plan for? In this episode of The Bearded Nerd Podcast, Brian breaks down how improvisation actually works for GMs, why it feels difficult at first, and how new Dungeon Masters can think on their feet without panic or railroading. This episode focuses on simple tools, practical frameworks, and real examples to help beginner GMs stay confident when sessions don't go according to plan. Topics Covered: Why improvisation feels scary for new GMs What improvisation really is (and isn't) How to respond logically to unexpected player choices Simple improv tools every GM can use How to keep the game moving without overthinking Perfect for new Game Masters running their first campaigns. Support the Podcast by subscribing and checking out this link

What does it mean to stay balanced and grounded in a shifting world?This episode of OffScript was recorded live at STEADY, the second event in Dash Arts' We Are Free To Change The World series. Through live performance and conversation, the evening focused on staying; on staying open without burning out, staying yourself in dialogue without collapsing into agreement or disagreement and staying human amid pressure, speed and polarisation.Hosted by Dash Arts' Artistic Director Josephine Burton, with Natasha Walter, Liz Slade, Tasneim Zyada, and Mohammed Ali, the contributors shared perspectives rooted in activism, faith, art and lived experience. Together, they reflect on what it means to remain grounded while responding to a world in flux — and how steadiness itself can be a radical, collective practice.Find out more about their work here:Natasha Walter - www.natashawalter.co.ukLiz Slade - www.elizabethslade.ukTasneim Zyada - www.instagram.com/tasneimzyadaMohammed Ali - www.artofmohammedali.comThe live event was co-presented by Dash Arts, Arts Admin and Fete of Britain.Get your tickets for the live events for We Are Free To Change The World by going to the Dash Arts website : https://www.dasharts.org.uk/we-are-free Our intro music is Fakiiritanssi by Marouf Majidi Hosted on Acast. See acast.com/privacy for more information.

The technologies are playing an increasingly central role in pharmaceutical manufacturing as companies contend with labor constraints, rising demand, and the need to modernize highly regulated operations.  In this episode of Off Script, we spoke with Alexander Shikany, executive vice president of the Association for Advancing Automation (A3), about how robotics adoption is reshaping pharma manufacturing today. The conversation explores why automation is now considered a core manufacturing strategy, where demand is emerging across the production lifecycle, how collaborative robots are gaining traction in regulated environments, and why human-in-the-loop automation remains essential for quality, compliance, and operational resilience.

RenMac unpacks the market fallout from Kevin Warsh emerging as the leading Fed chair candidate, the risks building in parabolic trades like gold and crypto and why sentiment extremes and “hair-trigger” psychology make these trades vulnerable to sharp reversals. The team also breaks down “momentum tech” and sector rotation risks, rising trade and shutdown risks, China-Taiwan tensions and why February seasonality could amplify market crosscurrents.

In this episode of Off Script, Josh, James, and Tom discuss the importance of innovation in Leeds and the broader UK, emphasizing the need for representation and funding for technology outside of London, triggered by an article Tom wrote titled "National purpose on AI". Tom shares insights on the historical context of innovation in Leeds, the role of academic research, and the success stories of tech companies in regions like Stoke-on-Trent. They also propose Manchester as a suitable location for Lovelace Labs and call for a national data library to be established in Leeds. The discussion highlights the need for a more confident and proactive approach to promoting Northern innovation and addressing funding disparities. The UK government often overlooks innovation happening outside London. Leeds has a rich history of innovation and should be recognized for it. The tech sector in Stoke-on-Trent is surprisingly larger than in Oxford. Academic research is crucial for innovation but often underfunded outside major cities. There is a need for a national data library to be based in Leeds. Manchester is a strong candidate for the proposed Lovelace Labs. Local companies need to be more vocal about their contributions to the economy. Funding for innovation should be more evenly distributed across the UK. The North should celebrate its successes and promote its strengths more actively. A cultural shift is needed to demand more respect and representation for Northern innovation.

As biopharma pipelines grow more complex, manufacturers are under increasing pressure to scale faster, adapt to new modalities, and build resilience into highly regulated operations. Meeting these demands means manufacturing agility is no longer just a competitive advantage, it's a necessity. Yet, structural constraints, talent shortages, and legacy processes continue to impact progress across the industry. In this episode of Off Script, we spoke with Iwan Roberts, vice president of technology and innovation strategy at Cytiva, for a deep dive into Cytiva's latest Global Biopharma Index. The conversation explores why manufacturing agility remains a major industry pain point, why modalities like cell and gene therapy and mRNA are uniquely difficult to scale, and how CDMOs, digitalization, and new supplier relationships are reshaping the path forward.  

Grief doesn't only come from loss we can name or explain. Sometimes it comes from shattered expectations—especially when someone we love chooses a path different from the one we imagined for them.In this episode, life coach Lindsey Shumway joins me to share a powerful and compassionate grief protocol she has taught to many of her clients—and recently used herself as her daughter took a direction Lindsay didn't expect.Lindsey opens up about her own experience with honesty and tenderness, then walks us through a simple but deeply meaningful 4-step process designed to help us move through grief rather than get stuck inside it. This protocol honors both love and disappointment, allowing space for pain without letting it define the relationship—or us.If you're grieving what could have been, what you hoped for, or what didn't turn out the way you planned, this conversation may offer exactly the support you've been looking for.Lindsey's books: I Chose You, 101 Creative Dates for Latter-day Saints, Teeny Tiny Talks, What Baptism Means to Me are available at www.cedarfort.comThe FREE Heart-Centered Breathing Meditation: https://meditation.hello-bliss.comThe Emotional Guidance Scale:  https://thejoywithin.org/authors/abraham-hicks/moving-up-the-emotional-guidance-scaleConnect with Lindsey at: www.hello-bliss.com, @helloblisslifecoachingConnect with Shiree at ⁠shireebest.com⁠ Join the⁠ "Just Love Them" Facebook group⁠Email Shiree at imlivinginjoy@gmail.com

"When Life Goes Off Script" - Daniel Self - 1.25.2026 by Orchard Audio Ministry

RenMac digs into the growing political stakes around the Fed chair decision, why global yields—especially in Japan—are reshaping risk appetite, and how improving breadth, regional banks, and small caps point to healthier market internals. The team also breaks down Davos takeaways on trade, rare earths, and China strategy, why good news for the economy doesn't always translate into good news for the markets, and what to watch next as yields, seasonality, and leadership trends evolve.

In this episode of Off Script, we continue our conversation with David Grote, vice president of strategy at GrayMatter Partners, focusing on the execution challenges that will define the success of today's pharmaceutical manufacturing investment boom. David explores the growing tension between speed, quality, and cost as companies race to bring new facilities online, and explains how early collaboration with regulators can help accelerate validation without sacrificing compliance or long-term resilience. He also discusses the strategic decisions that separate proactive manufacturers from reactive ones, the lasting impact this investment cycle will have on U.S. manufacturing footprints, and the expanding set of options that could open new opportunities for smaller companies.

This month we talk to the new artistic director of Dallas Theater Center and to the co-editors of a new online publication covering Off-Broadway

Offscript is American Theatre's flagship podcast, available wherever you get your podcasts (including Spotify and Apple Podcasts). Our first episode of 2026 features an interview with Dallas Theater Center’s recently named new artistic director, Jaime Castañeda, who tells about his background not only in Texas but all across the country (and in London) and about what he in store for Dallas theatregoers. We also chat with Kara Cutruzzula and Colin McDonald, founding co-editors of a new online publication about Off-Broadway theatre, readthehat.com, about how they choose their stories and what…

RenMac recaps key takeaways from the firm's 2026 Investor Forum, where stronger near-term data clashes with persistent weakness in housing and labor. Dutta argues inflation pressures continue to ease and deGraaf explains why that cooling inflation, improving breadth, and early strength in consumer discretionary point to a more constructive equity backdrop. Pavlick outlines why affordability is shaping energy, housing, and trade policy in a midterm year, while geopolitical tensions around China, Taiwan, and Venezuela remain underpriced. And the team dives into the Fed chair sweepstakes, debating Powell's staying power, the risks of politicized dissents, and what true Fed independence means for markets in 2026.

The episode kicks off with New Year's greetings and admiration for their guest, Al Sapienza, a versatile actor and entertainer. They read a note from Paul Anka, who plans to join a future episode, and then welcome Al to the show. Al discusses his career in acting, his love for performing, and his busy schedule with upcoming shows and television appearances, including a new TV show on Netflix called 'The Body' and Fox's 'Memory of a Killer.' He candidly shares his views on current political and social issues, expressing concern over the state of the nation and the principles of ambition and productivity. The conversation touches on personal anecdotes, his love for football, and experiences with various people in Hollywood. The hosts emphasize the importance of hard work and make light references to the challenges and changes in America. The episode wraps up with expressions of mutual admiration and best wishes for the new year.

After years of volatility, pharmaceutical manufacturing is entering a new investment cycle, with hundreds of billions of dollars flowing into U.S. facilities. The surge promises expanded capacity, but also raises questions about workforce availability, infrastructure readiness, and long-term execution. In this episode of Off Script, we spoke with David Grote, vice president of strategy at GrayMatter Partners, about what this wave of funding means in practice. The conversation explores where investment is concentrating, how competition for skilled talent is shaping project timelines, the strain on shared resources, and why flexible facility design will be critical to sustaining growth beyond today's political and economic cycle.

RenMac digs into a complicated January jobs report that dampens near-term rate-cut expectations as Dutta warns that unemployment risks are rising beneath stable headlines, while deGraaf points to an updated Market Cycle Clock, falling yields and trend signals that still support equities. Pavlick outlines growing policy uncertainty around tariffs, housing affordability, and Venezuela, and the team explores why markets continue to shrug off geopolitical risk, how healthcare and biotech are emerging as contrarian opportunities, and what investors should watch for as earnings season and inflation data take center stage.Our Outlook call is now available. Watch it here:https://start.renmac.com/2026outlook_lp

As a special offering in our Offscript feed, we offer this monologue by Gethsemane Herron, performed by Candace Boahene, about Harlem Renaissance writer, artist, and journalist Gwendolyn Bennett.

What does it take to prepare for change — artistically, emotionally, politically? This episode of OffScript was recorded live at the opening event in Dash Arts' We Are Free To Change The World series.Through performance and conversation, the event explored the conditions that help artists and creative activists find their ground to listen, to make, to resist, and to come together.Hosted by Dash Arts' Artistic Director Josephine Burton, the conversation features Bishi Bhattacharya, Lehni Lamide Davies, Carole Cadwalladr, and Sam Lee, reflecting on readiness rooted in care, courage, and collective imagination.Find out more about their work here:https://www.bishi.co.uk/ https://www.lehnilamide.com/contact https://broligarchy.substack.com/about http://samleesong.co.uk/ Get your tickets for the live events for We Are Free To Change The World by going to the Dash Arts website : https://www.dasharts.org.uk/we-are-free Our intro music is Fakiiritanssi by Marouf Majidi Hosted on Acast. See acast.com/privacy for more information.

Artificial intelligence is rapidly reshaping drug development by accelerating timelines, enabling more complex biologics, and changing how therapies are designed, delivered, and scaled. But as innovation speeds up, manufacturers face new challenges around delivery platforms, regulatory expectations, and operational agility. In this episode of Off Script, we spoke with Anthony Vico, Head of Business Line, US Technology Excellence Center at Stevanato Group, about how the industry is navigating this shift. The conversation explores the evolving role of drug delivery systems, where AI and machine learning are having the most immediate impact, how advanced therapeutic modalities fit into this changing landscape, and what manufacturers must do to remain competitive.

RenMac kicks off 2026 with a wide-ranging discussion on the political reality around affordability and inflation, asset allocation myths, and what to watch as ISM and employment data kick off the year. Dutta argues inflation pressures are easing faster than expected across housing, labor, and energy. deGraaf highlights emerging cyclicality beneath soft year-end trading, cautioning that extended moves in commodities and precious metals are entering bubble territory. And Pavlick outlines why tariff relief is increasingly consumer-focused, how Taiwan and China remain a central geopolitical risk, and why midterm dynamics will shape policy more than campaign rhetoric.

Justin Melo⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Justin Graver⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ are back to review the film on Tennessee Titans quarterback Cam Ward after his most recent performance against the New Orleans Saints, a bit of a roller coaster day of highs and lows. We also take a look at Ward's passing chart and close the show grading Ward's Week 17 performance in comparison to the other outings in his rookie season. NOTE: Watch this one on YouTube to see the actual film breakdowns: https://www.youtube.com/@musiccityaudiblepodcast 0:00 Teaser 0:37 General Thoughts 3:22 Passing Chart 9:05 Film Breakdown 25:16 Cam Ward Week 17 Grade 30:04 Final Thoughts ------------ The Music City Audible is presented by Sinker's Beverages in East Nashville and Bluegrass Beverages in Hendersonville. Join the Sinker's Beverages In Crowd: https://sinkers.storebyweb.com/s/1000-1/register ------------ Order Justin Melo's book "Titans of the South" here: https://shop.adventurewithkeen.com/product/titans-of-the-south/ ------------ Subscribe to the Podcast on YouTube: https://www.youtube.com/@musiccityaudiblepodcast

RenMac closes out 2025 by reflecting on the year's biggest macro, market, and political surprises as the team looks ahead to early 2026. deGraaf explains why seasonality and easing inflation remain underappreciated tailwinds, Dutta highlights the growing disconnect between strong GDP prints and weakening income and warns that unemployment — not growth — will drive the next phase of the cycle. And Pavlick breaks down why internal Republican divisions and the unresolved Fed chair search matter heading into midterms. The team also discusses consumer confidence, gold and metals strength, and late-year market positioning.

MERRY CHRISTMAS, YA'LL!!  What makes Kiss Kiss Bang Bang (2005) a Christmas movie? Is it that they wish each other a Merry Christmas a couple of times? Is it the Christmas lights in the park during the chase scene OR is it Michelle Monaghan's short Santa dress? Whatever the reason for the season, welcome to another one of IFW's Not-A-Christmas Movie Christmas Movie Special! ENJOY!     This episode is brought to you by: OFF-SCRIPT an awesome clothing brand by Tyler Budden, movie inspired clothing, without turning into cosplay! Music: https://jessejacethomas.bandcamp.com/album/want Create your podcast today! #madeonzencastr

In this episode of Off Script, we continue our conversation with Jason Bock, co-founder and CEO of CTMC, diving deeper into the operational and manufacturing challenges shaping the future of curative cell therapies. Jason discusses how CTMC—through its partnership with MD Anderson Cancer Center—is eliminating inefficiencies across development timelines to significantly accelerate clinical progress without increasing risk. He also shares a forward-looking perspective on how cell therapies could one day be ordered and delivered like traditional pharmaceuticals, and what scientific, regulatory, and manufacturing innovations will be required to make that vision a reality.

Sometimes, in life, there are movies that stand the test of time, that have an all-star cast, and some of the greatest storytelling brought to the big screen, and if you don't think Tropic Thunder hits all these points then you're cray cray! This movie is amazing and very very funny! We highly suggest watching this movie with your whole family and keep a very open mind! Enjoy!   This episode is brought to you by: OFF-SCRIPT an awesome clothing brand by Tyler Budden, movie inspired clothing, without turning into cosplay! Music: https://jessejacethomas.bandcamp.com/album/want Create your podcast today! #madeonzencastr  

RenMac breaks down a pivotal week where inflation cooled but global yields surged, suggesting the global bond markets—not just the U.S.— may be driving the next macro chapter. Dutta argues first principles matter on unemployment and inflation, deGraaf explains why the latter contracting is historically a quantifiable tailwind for equities and Pavlick examines China tensions from Panama to Taiwan and the continued political risks surrounding tariffs, defense spending, and Fed leadership.

Anything can happen when we're live, pal. What could possibly go wrong? Simon Miller presents 7 Worst Times Wrestlers Went Off Script On Live TV...ENJOY!Follow us on Twitter:@SimonMiller316@WhatCultureWWEFor more awesome content, check out: whatculture.com/wwe Hosted on Acast. See acast.com/privacy for more information.

Join hosts Javier from Pretend, Kristen Seavey from Murder She Told, and Shaun from Sins and Survivors for a special holiday crossover episode where three true crime podcasters let their guard down and talk shop. Featured Guests: Kristen Seavey, host of Murder She Told https://open.spotify.com/show/0n9q2IMjGQyrHMMByvnA2H?si=5975eb73d4714d07 Shaun, host of Sins and Survivors https://open.spotify.com/show/1W2swCx9LP38sFY06294pB?si=05c3269c69b94a73 Learn more about your ad choices. Visit podcastchoices.com/adchoices

Special bonus episode! Kristen is joined by fellow true crime podcasters Javier Leva from Pretend, and Shaun from Sins and Survivors for special "Podcasters on Podcasters" style crossover conversation where we let our guard down and talk shop. Follow Pretend and Sins and Survivors wherever you're listening now. Support the show: ⁠⁠⁠⁠https://www.murdershetold.com/support⁠⁠⁠⁠ Instagram: ⁠⁠⁠⁠⁠⁠@murdershetoldpodcast⁠⁠⁠⁠⁠⁠ TikTok: ⁠⁠⁠⁠⁠⁠@murdershetold⁠⁠⁠⁠⁠⁠ Facebook: ⁠⁠⁠⁠⁠⁠/mstpodcast⁠⁠⁠⁠⁠⁠ Website: ⁠⁠⁠⁠⁠⁠murdershetold.com⁠⁠⁠⁠⁠⁠ ---- Learn more about your ad choices. Visit podcastchoices.com/adchoices

What do you do when life doesn't go according to plan?We all carry a script for how things are supposed to go—career, relationships, marriage, kids, finances. And then something happens that blows the whole thing up. A breakup. A loss. A disappointment you never saw coming. Suddenly, it feels like God must be absent… because surely He wouldn't let this happen.In this message, we take a closer look at the life of Joseph—not the quiet guy in the nativity scene, but a real man facing real disruption. What looked like disaster to Joseph was actually God's plan unfolding in ways he couldn't yet see.This message is for anyone who feels like life has gone off-script.For anyone sitting in the mess.For anyone wondering if God is still at work.Because just because things don't look how you planned… doesn't mean God has left.Sometimes the mess is exactly where the miracle begins.

Autologous cell therapies have shown the promise of single-dose, curative treatments for patients with advanced cancers. But even with major scientific and regulatory progress, the field now faces its toughest challenge yet: achieving sustainable, scalable manufacturing for highly personalized therapies. In this episode of Off Script, we spoke with Jason Bock, co-founder and CEO of CTMC, a purpose-driven cell therapy accelerator. Jason discusses why scale remains the central barrier for autologous therapies, the significance of CTMC's partnership with MD Anderson Cancer Center, and how fit-for-purpose manufacturing models can shorten vein-to-vein time and bring transformative treatments to patients faster.

RenMac welcomes WSJ Correspondent Nick Timiraos to unpack a pivotal week for monetary policy. The team digs into why the January jobs print will determine whether the next cut is “live,” how hawkish dissents shaped Fed communications, and what the Chair succession battle means for policy credibility. deGraaf highlights improving market breadth and surprising strength across banks, metals, and equal-weight indices, while Dutta outlines a deteriorating labor market beneath the surface. And Pavlick breaks down Venezuela strategy, ACA deadlines, defense legislation, and a new outbound investment screen targeting China.

As a special offering in our Offscript feed, we share this monologue by Kevin Renn about the legendary fashion designer who gave the world the Playboy Bunny costume.